thempindo

  Strengthening Diphtheria Response in North Sumatera; Experts and Health Authorities Discuss Strategies On Thursday, March 12, the Expert (Komli) of North Sumatera, represented by Prof. dr. Ayodhia Pitaloka Pasaribu, MKed (Ped), SpA(K), Ph.D (Clin. Trop. Med), and dr. Restuti Hidayani Saragih, Sp.PD, K-PTI, FINASIM, M.H. (Kes), met with the Head of the North Sumatera […]

  SCOPE Pre-Implementation Stage Presented at the 9th International Conference on Plasmodium vivax Research 2025 (ICPvR 2025) On 12-14th February 2025, dr. Vincent Jimanto had the opportunity to present the Pre-Implementation Stage of the SCOPE study (Short COurse PrimaquinE for the radical cure of P. vivax) at the 9th International Conference on Plasmodium vivax Research

  ASTMH : Tafenoquine and ACTs – Evidence from Indonesia and Cambodia At the American Society of Tropical Medicine and Hygiene (ASTMH) conference held from November 13 to 17, 2024, Prof. Dr. Ayodhia P. Pasaribu, M.Ked(Ped), Sp.A(K), Ph.D (CTM), presented the use of tafenoquine and Artemisinin-based Combination Therapies (ACTs) in the treatment and prevention of

  Study of Diphteria: Tracking Diphteria in North Sumatera Corynebacterium diphtheriae has become a cause for concern because of its swift transmission and potentially deadly consequences, particularly in children who have not been fully vaccinated. Cases of diphtheria have recently resurged in several districts of North Sumatra. We are collaborating with Dinas Kesehatan Provinsi Sumatera

  HFMD Study: Update Hand, Foot, and Mouth Disease (HFMD) is back in the spotlight in the medical world. The research we conducted, there were 15 participants in Medan and this research is still ongoing to explore the characteristics of HFMD. This research is expected to provide new insights to reduce the spread of diseases

  HFMD Study : Training and Recruitment   On March 18 2024, training with the HFMD Study core team was first carried out at USU Hospital, guided by Mr. Ungke from OUCRU-ID. Apart from Medan, this research was also carried out with a team in Bali with a total cumulative target of case and control

  Learning the management of malaria from Timika City   From June 21 to June 23, 2022, the SHEPI team paid a visit to Timika City to gain firsthand insights into the ongoing malaria surveillance processes in the area. Prior research had been conducted on strengthening the healthcare system to improve primaquine effectiveness in Timika.

  EFFORT Study is getting closer to finalization   Finally, Progressive recruitment of EFFORT study on the site in Labuhan Rukupublic health center , was successful. So far 150 patients have been recruited at this sites. the number of screenings obtained was 357 patients. The total number of complete studies obtained was 141. The total

  G6PD training “SD Biosensor”: Pre-implementation preparation SCOPE study.   On August 3 – October 2, 2023 the SCOPE Medan team was represented by Dr. Vincent, Dr. Framita and Dr. Azkarunia attended the G6PD test training for 3 days in Hanura Puskesmas, Lampung as a preparation to start the pre-implementation phase of the study. The

  G6PD training “SD Biosensor”: Pre-implementation preparation SCOPE study.   EFFORT is a study which is evaluating the effectiviness of novel approaches to radical cure with tafenaquine and primaquine. This study is located in one of the health centers in Batubara, North Sumatra. Previously, the core team and staff of the health center (dr.Yulita, dr.